From: Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data
Pathway Name | p value | FDRc | Bc |
---|---|---|---|
(1) Metabolic pathways | 1.18 × 10\(^{-199}\) | 3.21 × 10\(^{-197}\) | 3.21 × 10\(^{-197}\) |
(2) Cytokine-cytokine receptor interaction | 3.14 × 10\(^{-84}\) | 4.27 × 10\(^{-82}\) | 8.53 × 10\(^{-82}\) |
(3) Pathways in cancer | 1.12 × 10\(^{-49}\) | 1.01 × 10\(^{-47}\) | 3.04 × 10\(^{-47}\) |
(4) Neuroactive ligand-receptor interaction | 5.60 × 10\(^{-36}\) | 3.81 × 10\(^{-34}\) | 1.52 × 10\(^{-33}\) |
(5) Pathways of neurodegeneration-multiple diseases | 2.09 × 10\(^{-33}\) | 1.14 × 10\(^{-31}\) | 5.69 × 10\(^{-31}\) |
(6) Transcriptional misregulation in cancer | 7.91 × 10\(^{-33}\) | 3.59 × 10\(^{-31}\) | 2.15 × 10\(^{-30}\) |
(7) MAPK signaling pathway | 4.41 × 10\(^{-31}\) | 1.71 × 10\(^{-29}\) | 1.20 × 10\(^{-28}\) |
(8) NOD-like receptor signaling pathway | 2.64 × 10\(^{-28}\) | 8.98 × 10\(^{-27}\) | 7.18 × 10\(^{-26}\) |
(9) Shigellosis | 9.48 × 10\(^{-28}\) | 2.86 × 10\(^{-26}\) | 2.58 × 10\(^{-25}\) |
(10) Proteoglycans in cancer | 1.94 × 10\(^{-27}\) | 5.29 × 10\(^{-26}\) | 5.29 × 10\(^{-25}\) |